Caitlyn Norman

Publikationer

2026

Caitlyn Norman, Dean Acreman, Meera Bissram, Blake Curtis, Sebastian Hamer, Folker Westphal, Michael Putz, Cristiana Stefan, Sarah R. Delaney, Rick Lines, Malcolm D. McLeod, Karen McDonald, Henrik Green (2026) Global emergence and ?-aminobutyric acid type A (GABAA) receptor activity of the new designer benzodiazepine ethylbromazolam Archives of Toxicology (Artikel i tidskrift) https://dx.doi.org/10.1007/s00204-026-04433-9

Giorgia Corli, Deborah Rudin, Dino Luethi, Matthias E. Liechti, Sabrine Bilel, Matteo Marti, Henrik Green, Manuela Monti, Caitlyn Norman (2026) 5-HT2A receptor agonism by tert-leucinamide and valinamide synthetic cannabinoids: In vitro and in vivo evidence British Journal of Pharmacology (Artikel i tidskrift) https://dx.doi.org/10.1111/bph.70457

Blake Curtis, Douglas J. Lawes, Mattias Persson, David Caldicott, Henrik Green, Caitlyn Norman, Malcolm D. McLeod (2026) Identification of isotocyanozene at an Australian drug checking service FORENSIC CHEMISTRY, Vol. 49, Artikel 100744 (Artikel i tidskrift) https://dx.doi.org/10.1016/j.forc.2026.100744

Caitlyn Norman, Sara Liin, Amaia Jauregi Miguel, Nina Ottosson, Henrik Green (2026) In vitro γ-aminobutyric acid A (GABA_A) receptor activity and binding interactions at the α⁺/γ₂^- interface of 53 prescription and designer benzodiazepines Communications Chemistry, Vol. 9, Artikel 155 (Artikel i tidskrift) https://dx.doi.org/10.1038/s42004-026-02001-x

2025

Manuela Monti, Tobias Rautio, Marie H. Deventer, Markus Schlapfer, Johannes Tveit, Alex J. Krotulski, Victoria Marland, Robert Reid, Niamh Nic Daeid, Craig McKenzie, Christophe P. Stove, Henrik Green, Caitlyn Norman (2025) Tail-less precursors in synthetic cannabinoid production: investigating a clandestine laboratory, seized samples, and CB1 activity Archives of Toxicology, Vol. 99, s. 3641-3661 (Artikel i tidskrift) https://dx.doi.org/10.1007/s00204-025-04086-0